Patent · US Active

CTLA4 proteins and their uses

US8642557B2 · kind B2 · utility

9Cited by
15References
43Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 11, 2011
Grant dateFeb 4, 2014
Priority date—
Expiry dateMar 11, 2031

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure relates to CTLA4 proteins and uses of such proteins, for example to treat diseases associated with the dysregulation of immune responses.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.